Does incorporating sequencing for TTN truncations improve genetic test sensitivity in patients with dilated cardiomyopathy?
Patients with familial or sporadic idiopathic dilated cardiomyopathy
Genetic testing incorporating sequencing approaches that detect TTN truncations
Detection of TTN truncating mutations (test sensitivity)
Incorporating TTN truncation sequencing into genetic testing for dilated cardiomyopathy substantially increases diagnostic sensitivity, as these mutations account for up to 25% of familial cases.
TTN truncating mutations are a common cause of dilated cardiomyopathy, occurring in approximately 25% of familial cases of idiopathic dilated cardiomyopathy and in 18% of sporadic cases. Incorporation of sequencing approaches that detect TTN truncations into genetic testing for dilated cardiomyopathy should substantially increase test sensitivity, thereby allowing earlier diagnosis and therapeutic intervention for many patients with dilated cardiomyopathy. Defining the functional effects of TTN truncating mutations should improve our understanding of the pathophysiology of dilated cardiomyopathy. (Funded by the Howard Hughes Medical Institute and others.).
Building similarity graph...
Analyzing shared references across papers
Loading...
Daniel S. Herman
Lien Lam
Matthew R.G. Taylor
New England Journal of Medicine
Harvard University
University of Washington
Howard Hughes Medical Institute
Building similarity graph...
Analyzing shared references across papers
Loading...
Herman et al. (Wed,) studied this question.
www.synapsesocial.com/papers/69d5721975589c71d767e4be — DOI: https://doi.org/10.1056/nejmoa1110186